RPL23AP64

Across TCGA pan-cancer cohorts, RPL23AP64 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RPL23AP64 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RPL23AP64 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL23AP64 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

THCA, KICH, and LUAD are the cancer types where RPL23AP64 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	II,III,IV	0.910	1.000	.003	66	view →
KICH	OS	Median	II,III,IV	0.761	1.000	.007	52	view →
LUAD	OS	Median	All	0.854	0.774	.011	38	view →
UVM	DFS	Quartile	II,III,IV	0.374	0.816	.009	37	view →
LGG	DFS	Tertile	All	0.755	0.889	<.001	32	view →
HNSC	DFS	Median	IV	0.392	0.250	.011	27	view →
READ	OS	Quartile	All	1.000	0.385	.002	26	view →
UCS	DFS	Median	IV	0.952	0.367	.001	24	view →
SKCM	OS	Median	III,IV	0.790	0.581	<.001	22	view →
LUSC	DFS	Median	III,IV	0.569	0.741	.022	17	view →
ACC	DFS	Quartile	All	0.418	0.856	.015	16	view →
CESC	DFS	Median	All	0.768	0.877	.004	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RPL23AP64–THCA (OS)

Open the THCA breakdown →